Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News OpGen Inc OPGN

Healthcare Biotechnology

OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company distributes molecular microbiology solutions that help guide clinicians with more information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The Company's... see more

Add To Watchlist

Recent & Breaking News (OTCPK:OPGN)

(LD Micro) 360 Companies Set to Present this Week

Accesswire August 31, 2020

OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19

GlobeNewswire August 20, 2020

OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire August 12, 2020

OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

GlobeNewswire August 11, 2020

OpGen Co-Markets COVID-19 Antibody Test Kit

GlobeNewswire August 9, 2020

OpGen to Provide Business Update and Financial Results for the Second Quarter 2020

GlobeNewswire August 5, 2020

OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2020

GlobeNewswire July 15, 2020

Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

GlobeNewswire July 13, 2020

OpGen Subsidiary Curetis GmbH Secures Access to Additional EUR 5.0 Million Non-Dilutive Debt Financing Tranche from EIB

GlobeNewswire July 9, 2020

OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19 Patients in Just Five Hours

GlobeNewswire June 9, 2020

OpGen Expands Partnership with New York State Department of Health and IDC to Detect Antimicrobial-Resistant Infections

GlobeNewswire June 3, 2020

OpGen CEO and Chairman of the Board Issue Letters to Stockholders

GlobeNewswire May 11, 2020

OpGen Reports First Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire May 7, 2020

OpGen to Provide Business Update and Financial Results for the First Quarter 2020

GlobeNewswire April 27, 2020

OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients

GlobeNewswire April 21, 2020

OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study

GlobeNewswire April 16, 2020

OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update

GlobeNewswire April 14, 2020

OpGen and Curetis Successfully Close their Business Combination Transaction

GlobeNewswire April 1, 2020

OpGen Announces Shareholder Approval for Business Combination with Curetis

GlobeNewswire March 30, 2020

OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update for OpGen and Curetis Group

GlobeNewswire March 24, 2020